Can Esketamine Be Used to Prevent Postpartum Depression?
Emerging evidence suggests perioperative esketamine may reduce postpartum depression risk and improve recovery; however, information regarding long-term efficacy and optimal use is limited.
Harnessing the Power of Peer-Delivered Interventions for Perinatal Mood and Anxiety Disorders
Developed for use in low-resource communities, interventions using non-specialist peers as providers can be used to deliver effective, evidence-based treatment for perinatal depression and anxiety.
Massachusetts Considers Bill to Prioritize Treatment Over Punishment for New Mothers with Postpartum Psychiatric Illness
The bill would ensure mental health evaluations by reproductive psychiatry experts, ensure treatment when needed, and recognize postpartum psychosis as a mitigating factor in sentencing.
Unraveling the Complexities of Perinatal Suicide: Insights from Women’s Lived Experiences
This study uncovers how trauma, isolation, loss of identity, and lack of support can overlap and amplify each other, deepening despair and driving suicide risk among women in the perinatal period.
What About Dads? How We Can Improve Screening for Perinatal Mood and Anxiety Disorders
Although up to 10% of new fathers may experience mental health challenges, we do not regularly screen this population.
Essential Reads: Postpartum Depression, Is it Unipolar or Bipolar?
Vigilance is required in screening women who present with postpartum depression; a subset of women who screen positive for depression may actually have bipolar disorder.
Psychological Interventions for Perinatal Anxiety Symptoms: Do They Work?
Psychological interventions may reduce the severity of perinatal anxiety symptoms.
ADHD as a Risk Factor for Postpartum Depression and Anxiety
ADHD is an important risk factor for both depression and anxiety disorders in the postpartum period and should be considered in the post-pregnancy maternal care.
Planned Initiatives from the Department of Health and Human Services Focus on Maternal Mental Health
 Some good news from our colleagues at the Maternal Mental Health Leadership Alliance (MMHLA)... The United States Department of Health and Human Services (HHS) is planning to launch significant initiatives addressing the maternal mental [...]
Post-Marketing Safety Data for Brexanolone (Zulresso)
In this postmarketing surveillance data analysis, excessive sedation and loss of consciousness when receiving brexanolone occurred at lower rates than previously reported in clinical trials.